Envestnet Asset Management Portfolio holdings
Envestnet Asset Management, a subsidiary of Envestnet, Inc., founded in 1999 by Jud Bergman and Bill Crager, is a Chicago-based financial technology firm that provides wealth management solutions and software to financial advisors and institutions, managing over $426 billion in discretionary assets as of late 2024. Headquartered at 35 East Wacker Drive, it serves a vast network, including over 111,000 advisors and major U.S. banks, with a platform overseeing more than $6.5 trillion in assets, offering tools like portfolio management, trading, and reporting through an integrated ecosystem. Known for its innovative AdvisorSuite software and Portfolio Management Consultants (PMC) division, Envestnet supports advisors with sub-advisory services, research, and data analytics, bolstered by its 2015 acquisition of Yodlee for enhanced data aggregation. Recently acquired by a Bain Capital-led consortium for $4.5 billion in November 2024, Envestnet continues to evolve as a private entity, focusing on scalable, tech-driven wealth management solutions.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$921M |
| 2 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$803M |
| 3 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$732M |
| 4 |
iShares ESG Aware MSCI EM ETF
ESGE
|
+$441M |
| 5 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$383M |
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$405M |
| 2 |
SPDR Portfolio S&P 500 Value ETF
SPYV
|
+$397M |
| 3 |
iShares MBS ETF
MBB
|
+$210M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$178M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$164M |
Sector Composition
| 1 | Technology | 4.89% |
| 2 | Healthcare | 4% |
| 3 | Financials | 3.25% |
| 4 | Consumer Discretionary | 2.2% |
| 5 | Industrials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRI
2726
DELISTED
Atrion Corp
ATRI
| $202K | ﹤0.01% |
310
-75
| -19% | -$48.9K |
|
2727
Nova
NVMI
$8.11B
| $201K | ﹤0.01% |
6,119
-852
| -12% | -$28K |
|
|
AGR
2728
DELISTED
Avangrid, Inc.
AGR
| $201K | ﹤0.01% |
+4,585
| New | +$201K |
|
2729
Franklin FTSE United Kingdom ETF
FLGB
$852M
| $200K | ﹤0.01% |
+11,255
| New | +$200K |
|
2730
Global X Lithium & Battery Tech ETF
LIT
$1.14B
| $200K | ﹤0.01% |
9,197
+881
| +11% | +$19.2K |
|
2731
Sabesp
SBS
$15.9B
| $200K | ﹤0.01% |
27,046
-62,677
| -70% | -$463K |
|
2732
Supernus Pharmaceuticals
SUPN
$2.58B
| $200K | ﹤0.01% |
11,096
-5,230
| -32% | -$94.3K |
|
2733
Atlanta Braves Holdings Series B
BATRK
$2.66B
| $199K | ﹤0.01% |
10,437
-314
| -3% | -$5.99K |
|
2734
Veritex Holdings
VBTX
$1.88B
| $199K | ﹤0.01% |
+14,280
| New | +$199K |
|
|
VRE
2735
Veris Residential
VRE
$1.51B
| $199K | ﹤0.01% |
13,083
+3,199
| +32% | +$48.7K |
|
2736
CareTrust REIT
CTRE
$7.68B
| $198K | ﹤0.01% |
+13,384
| New | +$198K |
|
2737
iShares Latin America 40 ETF
ILF
$1.77B
| $196K | ﹤0.01% |
10,759
+901
| +9% | +$16.4K |
|
2738
Olin
OLN
$2.87B
| $196K | ﹤0.01% |
16,784
-57,445
| -77% | -$671K |
|
2739
Axcelis
ACLS
$2.57B
| $192K | ﹤0.01% |
+10,476
| New | +$192K |
|
2740
Gray Television
GTN
$634M
| $191K | ﹤0.01% |
17,827
+749
| +4% | +$8.03K |
|
2741
Sasol
SSL
$4.38B
| $191K | ﹤0.01% |
95,245
-8,072
| -8% | -$16.2K |
|
|
RTLR
2742
DELISTED
Rattler Midstream LP Common Units
RTLR
| $189K | ﹤0.01% |
54,194
-1,929
| -3% | -$6.73K |
|
|
FPF
2743
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.17B
| $188K | ﹤0.01% |
10,555
+1,196
| +13% | +$21.3K |
|
2744
Nuveen Core Equity Alpha Fund
JCE
$266M
| $188K | ﹤0.01% |
+17,524
| New | +$188K |
|
|
MTOR
2745
DELISTED
MERITOR, Inc.
MTOR
| $188K | ﹤0.01% |
14,177
+4,472
| +46% | +$59.3K |
|
|
YRD
2746
Yiren Digital
YRD
$494M
| $187K | ﹤0.01% |
+46,565
| New | +$187K |
|
2747
APA Corp
APA
$7.75B
| $186K | ﹤0.01% |
44,581
+25,724
| +136% | +$107K |
|
|
ETV
2748
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.65B
| $186K | ﹤0.01% |
+15,401
| New | +$186K |
|
2749
Macerich
MAC
$4.68B
| $186K | ﹤0.01% |
32,993
-14,344
| -30% | -$80.9K |
|
2750
Puma Biotechnology
PBYI
$230M
| $186K | ﹤0.01% |
22,057
+10,619
| +93% | +$89.5K |
|